[go: up one dir, main page]

BR9712705A - Composição para o tratamento da asma, contendo loratadina e um descongestionante - Google Patents

Composição para o tratamento da asma, contendo loratadina e um descongestionante

Info

Publication number
BR9712705A
BR9712705A BR9712705-1A BR9712705A BR9712705A BR 9712705 A BR9712705 A BR 9712705A BR 9712705 A BR9712705 A BR 9712705A BR 9712705 A BR9712705 A BR 9712705A
Authority
BR
Brazil
Prior art keywords
asthma
treatment
decongestant
composition
containing loratadine
Prior art date
Application number
BR9712705-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Alan G Harris
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BR9712705A publication Critical patent/BR9712705A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9712705-1A 1996-10-31 1997-10-29 Composição para o tratamento da asma, contendo loratadina e um descongestionante BR9712705A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31
PCT/US1997/019158 WO1998018470A1 (fr) 1996-10-31 1997-10-29 Composition destinee au traitement de l'asthme et contenant de la loratadine et un decongestionnant

Publications (1)

Publication Number Publication Date
BR9712705A true BR9712705A (pt) 1999-10-26

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712705-1A BR9712705A (pt) 1996-10-31 1997-10-29 Composição para o tratamento da asma, contendo loratadina e um descongestionante

Country Status (21)

Country Link
EP (1) EP0941091A1 (fr)
JP (1) JP2000505104A (fr)
KR (1) KR20000052922A (fr)
CN (1) CN1235545A (fr)
AR (1) AR008908A1 (fr)
AU (1) AU731756B2 (fr)
BR (1) BR9712705A (fr)
CA (1) CA2268546A1 (fr)
CO (1) CO4910128A1 (fr)
CZ (1) CZ150999A3 (fr)
HU (1) HUP9904075A3 (fr)
ID (1) ID23431A (fr)
IL (1) IL129662A0 (fr)
NO (1) NO992062D0 (fr)
NZ (1) NZ335078A (fr)
PE (1) PE11399A1 (fr)
PL (1) PL333056A1 (fr)
SK (1) SK54599A3 (fr)
TR (1) TR199901003T2 (fr)
WO (1) WO1998018470A1 (fr)
ZA (1) ZA979731B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1205799A (en) * 1997-10-29 1999-05-17 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
WO2000015226A1 (fr) * 1998-09-10 2000-03-23 Schering Corporation Anti-histamines traitant la sinusite ou l'otite moyenne non infectieuse
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
EP1154762B1 (fr) * 1999-02-23 2003-11-05 Yuhan Corporation Compositions de capsules pharmaceutiques contenant de la loratadine et de la pseudoephedrine
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
AU3924500A (en) * 1999-03-29 2000-10-16 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
SK287105B6 (sk) * 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
SK287684B6 (sk) * 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
CA2405238C (fr) * 2000-04-14 2014-03-18 J-Med Pharmaceuticals, Inc. Formulations antihistaminiques/decongestionnantes a dose unique
WO2001089527A2 (fr) * 2000-05-24 2001-11-29 Schering Corporation Compositions solides et liquides stables
HUP0401630A2 (hu) * 2001-06-20 2004-12-28 Schering Corp. Antihisztaminok alkalmazása nazális vérbőség és orrdugulás kezelésére szolgáló gyógyszerkészítmény előállítására
RU2423979C2 (ru) * 2005-06-17 2011-07-20 АФТ Фармасьютикалз Лимитед Новая фармацевтическая композиция и ее применение в способе лечения пациентов с гиперемией и отеком слизистой оболочки верхних дыхательных путей
CA2612179C (fr) 2005-06-17 2016-08-02 Aft Pharmaceuticals Limited Une composition pharmaceutique comprenant de la loratadine et son utilisation pour traiter les patients atteints de congestion des muqueuses des voies respiratoires superieures
CL2007001584A1 (es) * 2006-06-01 2008-01-25 Msd Consumer Care Inc Composicion farmaceutica que comprende: un nucleo con fenilefrina en forma de liberacion inmediata y una capa erosionable que comprende fenilefrina y una matriz de liberacion sostenida; util para tratar los sintomas del resfriado, influenza, alergias o rinitis no alergicas.
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
KR101540191B1 (ko) * 2014-02-24 2015-07-28 성균관대학교산학협력단 로라타딘을 포함하는 항염증용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
NO992062L (no) 1999-04-29
NO992062D0 (no) 1999-04-29
CZ150999A3 (cs) 1999-10-13
HUP9904075A2 (hu) 2000-05-28
NZ335078A (en) 2000-10-27
AR008908A1 (es) 2000-02-23
PL333056A1 (en) 1999-11-08
CA2268546A1 (fr) 1998-05-07
ID23431A (id) 2000-04-20
KR20000052922A (ko) 2000-08-25
AU4995397A (en) 1998-05-22
AU731756B2 (en) 2001-04-05
ZA979731B (en) 1998-04-29
IL129662A0 (en) 2000-02-29
CO4910128A1 (es) 2000-04-24
CN1235545A (zh) 1999-11-17
JP2000505104A (ja) 2000-04-25
PE11399A1 (es) 1999-02-09
SK54599A3 (en) 2000-08-14
TR199901003T2 (xx) 1999-07-21
HUP9904075A3 (en) 2002-02-28
WO1998018470A1 (fr) 1998-05-07
EP0941091A1 (fr) 1999-09-15

Similar Documents

Publication Publication Date Title
BR9712705A (pt) Composição para o tratamento da asma, contendo loratadina e um descongestionante
EP1007556A4 (fr) Sous-unites et fragments de troponine utiles comme inhibiteurs de l'angiogenese
BRPI0109131B8 (pt) dna, vetor de expressão compreendendo o mesmo, fator viii modificado de porcino, seu processo de produção e composição terapêutica compreendendo o mesmo
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
BR9911666A (pt) Combinação farmacêutica, uso da combinação, processo para tratamento de uma doença inflamatória em uma pessoa sofrendo de ou susceptìvel a tal doença, e, composição farmacêutica
FI965203A7 (fi) Morfiinia, polypyrrolidonia ja polyalkyleenioksidia sisältävä koostumus
FI962990L (fi) Menetelmä rekombinanttisten adenovirukseen assosioituvien virusten (AAV:iden) valmistamiseksi ja sen käyttöjä
ITMI941252A0 (it) Composizione catalitica e processo per l'alchilazione di composti aromatici
ID30385A (id) Komposisi penghilang infeksi berbahan dasar h202, asam dan ion-ion logam
IT1290846B1 (it) Composizione catalitica e processo per l'alchilazione e/o la transalchilazione di composti aromatici
EP1001782A4 (fr) 5,6-HETEROARYL-DIPYRIDO 2,3-$i(b):3',2'-$i(f)]AZEPINES ET LEUR UTILISATION DANS LA PREVENTION OU LE TRAITEMENT DE L'INFECTION PAR LE VIH
CA2304657A1 (fr) Traitement du trouble des conduites
IL140118A0 (en) Use of optically pure (+) norcisapride for treating apnea, bulimia and other disorders
BR9809022A (pt) Composições antiinflamatórias nasais tópicas
BR9710390B1 (pt) processo para preparação de sìlica compatìvel com aromatizantes, utilização da sìlica, e, composição dentifrìcia.
BR9913072A (pt) Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia
BR9813996A (pt) 2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio
PE118999A1 (es) Composiciones y metodos para tratar trastornos respiratorios
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
DE69411726D1 (de) Zusammensetzungen zur freigabe einer aromatischen substanz in die nase
BR0103710A (pt) Proteção de fibras queratinosas usando ceramidas e/ou glicoceramidas
BR8806062A (pt) Processo para a preparacao de uma composicao concentrada estavel,bombeavel e despejavel,processo para a preparacao de uma composicao amaciante de tecidos,composicao concentrada,e composicao para tratamento de texteis
BR0113650A (pt) N-(3,5-dicloro-2-metoxifenil)-4-metóxi-3-piperazina-1-il a-benzenossulfonamida
BR9712767A (pt) Expressão especìfica para tecido de proteìna de retinoblastoma

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal